Existing drugs could benefit one in five breast cancer patients
A genetic study of breast cancer patients suggests that existing drugs for treating rare breast and ovarian cancers may help more patients than previously thought...
A genetic study of breast cancer patients suggests that existing drugs for treating rare breast and ovarian cancers may help more patients than previously thought...
A study has indicated that US doctors may not be recommending genetic testing to a sufficient number of high-risk breast cancer patients...
Angelina Jolie's 2013 public announcement that she has the BRCA1 breast cancer gene led to a 64 percent increase in women seeking genetic testing for breast cancer...
Do you know who owns your genome? And who, if anyone, would you choose to give your genetic information to? This debate, organised by the British Science Association and supported by Genomics England, covered the cutting-edge issues in genomic ethics and legality...
The FDA has warned that it does not recommend the use of any currently available ovarian cancer screening tests to detect the disease...
Researchers have developed a new pathway for genetically testing ovarian cancer patients which they say will save both lives and money...
Genetic mutations on several genes including BRCA2 have been associated with prostate cancer; while in a separate study, a BRCA1 mutation has been linked to a particular form of uterine cancer...
A drug currently used to treat osteoporosis in old age may help prevent breast cancer in women with a genetic predisposition for the disease...
After one year of existence, the BRCA Share database has released details on its progress in collating information on variants of the BRCA1 and BRCA2 genes...
Myriad Genetics has been hit by a complaint filed by the American Civil Liberties Union (ACLU) on behalf of four patients who are seeking a right of access to all their genetic information held by the company...
BioNews, published by the Progress Educational Trust (PET), provides news and comment on genetics, assisted conception, embryo/stem cell research and related areas.